Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
[signup] Key Takeaways BPC 157 has shown promise in various medical contexts, including promoting tissue healing, managing inflammation, and supporting gut health
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
View the Phase 2 retatrutide trial on PubMed
Some people may be at risk of vitamin B12 if they are on a vegan diet and fail to get enough B12 through food
We cover that, as well as what you can individuall do before and after your treatments to make them more effective, in this blog
Let our team know how we can help with your goals
US$ 22.04
US$ 21.11
US$ 22.83
US$ 21.36
US$ 28.13
US$ 20.31
US$ 22.62
US$ 29.09
